Delivery Order SPE2DB20D3103-SPE2DB25FN7V6
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a Ceiling Value of $10,540.50 and an Ultimate Completion Date of June 9, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Naloxone HCL 4 mg nasal spray. The contract has a firm fixed price of $1,315.00 and a period of performance through May 6, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Naloxone HCL 4 mg nasal spray, with a ceiling value of $16,431.92 and a performance period through April 29, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone HCL 4 mg nasal spray, with a ceiling value of $3,446.87 and a performance period ending on May 15, 2025. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Naloxone HCl 4 mg nasal spray. The contract has a firm fixed price of $2,997.38 and a period of performance through April 23, 2025. This order is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
This is a Delivery Order award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg naloxone hydrochloride nasal spray. The total ceiling value of the contract is $1,357.92 and the ultimate completion date is July 12, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Naloxone HCl nasal spray. The contract has a ceiling value of $9,645.38 and a completion date of December 13, 2023. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naloxone HCL 4 mg nasal spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,197.16 and an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg naloxone hydrochloride nasal spray. The contract, valued at $5,276.24, has a firm fixed price and is set to expire on August 8, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...